Intellia Therapeutics (NTLA, $26.46) was one of top quarterly gainers, jumping +2 to $26.46 per share. A.I.dvisor analyzed 873 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.